Get the CORT Research Report and
Also Receive Our Top Trades for 2016!

Corcept Therapeutics Incorporated

Corcept reported revenue of $23.8 million for the fourth quarter of 2016 and $81.3 million for the full year. The company also increased its 2017 revenue guidance from $115 – $125 million to $120 – $130 million. GAAP net income for the fourth quarter of 2016 was $4.6 million, or $0.04 per share, compared to net income of $1.0 million, or $0.01 per share, in the fourth quarter of 2015. For the full year, the company reported GAAP net income of $8.1 million, or $0.07 per share, compared to a net l … (See Research Report)
Download Research Report
on CORT Now